Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    mdx-1106 hcv
Show Display Options
Rank Status Study
1 Completed A Study of MDX-1106 to Treat Patients With Hepatitis C Infection
Condition: Hepatitis C
Interventions: Drug: MDX1106-02;   Drug: Placebo
2 Recruiting A Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab and the Combination Nivolumab Plus Ipilimumab in Patients With Advanced Liver Cancer
Condition: Hepatocellular Carcinoma
Interventions: Biological: Nivolumab;   Drug: Sorafenib;   Drug: Ipilimumab

Study has passed its completion date and status has not been verified in more than two years.